Trials / Withdrawn
WithdrawnNCT02677818
The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Zhujiang Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Plasma Factor VIII Levels are related to the treatment of bleeding in ischemic stroke（IS）.
Detailed description
Clear cerebral infarction patients during hospitalization, treatment process, discharge and hemorrhage occurs, the stages F VIII level change and its correlation with bleeding adverse reactions. Analysis F VIII whether belong to hemorrhage occurs independent risk factors of adverse drug reactions,as well as the feasibility of predicting bleeding occurred adverse reaction index.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-01-01
- Completion
- 2021-08-01
- First posted
- 2016-02-09
- Last updated
- 2022-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02677818. Inclusion in this directory is not an endorsement.